Matches in Wikidata for { <http://www.wikidata.org/entity/Q64801287> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q64801287 description "clinical trial" @default.
- Q64801287 description "ensayu clínicu" @default.
- Q64801287 description "klinisch onderzoek" @default.
- Q64801287 description "клінічне випробування" @default.
- Q64801287 name "Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)" @default.
- Q64801287 type Item @default.
- Q64801287 label "Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)" @default.
- Q64801287 prefLabel "Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)" @default.
- Q64801287 P1050 Q64801287-C90FC58A-E4AA-4360-8BD1-45AC76D3AC3A @default.
- Q64801287 P1132 Q64801287-9F6CBA1A-4D37-4F39-8725-E8CAB5379A14 @default.
- Q64801287 P1476 Q64801287-0E185866-0AF9-47CC-BDB7-9A621F9831D9 @default.
- Q64801287 P17 Q64801287-F52FF693-2FA2-4692-BD89-7798907BA7C9 @default.
- Q64801287 P2899 Q64801287-EDDDED93-1F89-48C7-BD07-FD50639C3032 @default.
- Q64801287 P3098 Q64801287-1BA1A880-A8A0-411D-A7DA-87B651DDA673 @default.
- Q64801287 P31 Q64801287-B8FF12BC-BEFB-420C-BCA3-55068E8AA164 @default.
- Q64801287 P4135 Q64801287-B1575D00-241A-4F24-BC29-9DD20D3CE2D2 @default.
- Q64801287 P4844 Q64801287-21A3BF50-52D5-4326-84A1-F3638DE10EA0 @default.
- Q64801287 P4844 Q64801287-22982F8D-5628-4DC0-B2E4-16196B09AF44 @default.
- Q64801287 P4844 Q64801287-F45474D4-3D24-4EEE-98D3-9249910A5D2B @default.
- Q64801287 P580 Q64801287-F1DE5D69-9031-4016-A33B-6B144D85BEF3 @default.
- Q64801287 P582 Q64801287-89002024-5215-4B93-B04E-81F65ACB44D9 @default.
- Q64801287 P6099 Q64801287-4A21E60C-A682-40FC-B071-13BFA5B3AE07 @default.
- Q64801287 P8363 Q64801287-2B686399-BC53-48D2-B7F1-5F76A08864CB @default.
- Q64801287 P1050 Q12206 @default.
- Q64801287 P1132 "+254" @default.
- Q64801287 P1476 "A Randomized, 24-week, Controlled, Open Label, Parallel Arm, Multicenter Study Comparing the Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Type 2 Diabetes Patients, Inadequately Controlled on Basal Insulin With or Without Metformin" @default.
- Q64801287 P17 Q668 @default.
- Q64801287 P2899 "+18" @default.
- Q64801287 P3098 "NCT03529123" @default.
- Q64801287 P31 Q30612 @default.
- Q64801287 P4135 "+64" @default.
- Q64801287 P4844 Q19484 @default.
- Q64801287 P4844 Q6042242 @default.
- Q64801287 P4844 Q6659956 @default.
- Q64801287 P580 "2018-06-19T00:00:00Z" @default.
- Q64801287 P582 "2019-12-01T00:00:00Z" @default.
- Q64801287 P6099 Q42824827 @default.
- Q64801287 P8363 Q78089383 @default.